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肺磨玻璃结节临床研究进展
李镭  刘丹  朱盈盈  李为民
【摘要】 磨玻璃结节（ground-glass nodules, GGNs）是肺结节中的特殊类型，随着高分辨薄层计算机断层扫描
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【Abstract】 Ground-glass nodules (GGNs) was a special type of pulmonary nodules. With the progress of high reso-
lution CT (HRCT), it achieved a higher positive rate and attracted much attention in recent years. For lacking characteristic 
symptoms, the early diagnosis of lung cancer was difficult even nowadays. However, it had been proved that GGNs was well 
associated with lung cancer in previous studies. Therefore, optimized managements of GGNs could help diagnosis and treat-
ments of lung cancer at early stage. In this review, we summarized the definition, classification, imaging characteristics, growing 
history, molecular pathological features and suggested managements of GGNs.
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随着计算机断层扫描（ c o m p u t e d  t o m o g r a p h y , 


















病变，如局灶性间质纤维化（focal interstitial f ibrosis, 
FIF）、感染、出血、水肿等；可为腺癌浸润前病变，
如原位腺癌（adenocarcinoma in s itu ,  AIS）、非典型
腺瘤样增生（atypical adenomatous hyperplasia, AAH）
等；也可为恶性病变，如微浸润性腺癌（m i n i m a l l y 
invasive adenocarcinoma, MIA）、浸润性腺癌（invasive 
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adenocarcinoma, IA）等[3,4]。






















（broncholoalveolar cell carcinoma, BAC）（n=36）、以BAC
为主的腺癌（n=4）。
3    GGNs与肺腺癌病理分型、影像学特征的相关性研究
2 0 1 1 年 ， 国 际 肿 瘤 研 究 协 会 （ I n t e r n a t i o n a l 
Association for the Study of Lung Cancer, IASLC）、美国胸科
协会（American Thoracic Society, ATS）以及欧洲呼吸学会
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GGNs，确诊方式包括手术、活检及临床诊断，恶性构成
比分别为74.3%、51.0%，明显低于前者。










4度（>75%, n=3），其恶性构成比（83%, 100%, 100%, 
100%）无明显差别。
4.3  GGNs边缘及内部征象与肺癌  一项纳入82例GGNs
的研究发现，分叶征（14.3 vs  83.6,  P<0.001）、短毛
刺征（4.8 vs  34.4, P=0.008）、长毛刺征（0.0 vs  29.5, 
P=0.004）、边界不清（66.7 vs  1.6,  P<0.001、不规则
边缘（33.3 vs  93.4, P<0.001）、含气征（14.3 vs  59.0, 
P<0.001）、胸膜凹陷征（4.8 vs 70.5, P<0.001）、血管集





















9 0 %。但对于G G N s而言，由于其生长代谢不活跃，
PET/CT较易出现假阴性。Chun等[30]对68例GGNs研究发
现：恶性pGGNs与良性pGGNs相比，SUV值接近[(0.64±
0.19), range 0.43-0.96; (0.74±0.28), range 0.32-1.00]，差异无
统计学意义（P=0.37）；而恶性mGGNs与良性mGGNs












































































图 1  GGNs诊治流程建议
Fig 1  Suggested guideline for management of GGNs. CT: computed tomography; HRCT: high resolution CT; GGNs: ground-glass nodules; pGGNs: 
pure GGNs; PET/CT: positron emission tomography/computed tomography.
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